Skip to content

Selectis Health, Inc.: 10-Q filed 2017-11-20

What Selectis Health, Inc. reported in its quarterly report filed 2017-11-20 (fiscal Q3 2017): 29 published measures, 86 facts as tagged in accession 0001493152-17-013541.

This filing

Form
10-Q (quarterly report)
Filed
2017-11-20
Fiscal period
fiscal Q3 2017
Accession
0001493152-17-013541 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Selectis Health, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2017-09-3039,264,978USD
At 2016-12-3137,543,832USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2017-09-3035,457,183USD
At 2016-12-3133,009,517USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2017-09-304,008,106USD
At 2016-12-314,712,576USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2017-09-30105,485USD
At 2016-12-31578,242USD
At 2016-09-301,352,015USD
At 2015-12-3171,055USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2017-07-01 to 2017-09-30-449,044USD92
2017-01-01 to 2017-09-30-1,350,295USD273
2016-07-01 to 2016-09-30355,827USD92
2016-01-01 to 2016-09-30-296,299USD274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2017-01-01 to 2017-09-30103,702USD273
2016-01-01 to 2016-09-30-506,278USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2017-01-01 to 2017-09-30176,280USD273
2016-01-01 to 2016-09-30-885,500USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2017-01-01 to 2017-09-30-752,739USD273
2016-01-01 to 2016-09-302,672,738USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2017-09-30-7,394,698USD
At 2016-12-31-6,021,903USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2017-07-01 to 2017-09-3025,899,337shares92
2017-01-01 to 2017-09-3025,697,705shares273
2016-07-01 to 2016-09-3023,802,472shares92
2016-01-01 to 2016-09-3022,791,649shares274

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2017-07-01 to 2017-09-3025,899,337shares92
2017-01-01 to 2017-09-3025,697,705shares273
2016-07-01 to 2016-09-3023,377,972shares92
2016-01-01 to 2016-09-3022,791,649shares274

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2017-07-01 to 2017-09-30-0.02USD/shares92
2017-01-01 to 2017-09-30-0.05USD/shares273
2016-07-01 to 2016-09-300.01USD/shares92
2016-01-01 to 2016-09-30-0.01USD/shares274

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2017-07-01 to 2017-09-30-0.02USD/shares92
2017-01-01 to 2017-09-30-0.05USD/shares273
2016-07-01 to 2016-09-300.01USD/shares92
2016-01-01 to 2016-09-30-0.01USD/shares274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2017-09-3037,985,136USD
At 2016-12-3136,162,881USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2017-07-01 to 2017-09-3086,886USD92
2017-01-01 to 2017-09-30131,560USD273
2016-07-01 to 2016-09-30-215,015USD92
2016-01-01 to 2016-09-30237,138USD274

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2017-07-01 to 2017-09-30-583,453USD92
2017-01-01 to 2017-09-30-1,723,252USD273
2016-07-01 to 2016-09-30-603,511USD92
2016-01-01 to 2016-09-30-1,971,025USD274

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2017-07-01 to 2017-09-30662,383USD92
2017-01-01 to 2017-09-302,171,795USD273
2016-07-01 to 2016-09-301,065,535USD92
2016-01-01 to 2016-09-302,073,446USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2017-09-3026,289,352shares
At 2016-12-3125,027,260shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2017-09-309,312,337USD
At 2016-12-318,707,116USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2017-09-303,807,795USD
At 2016-12-314,534,315USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2017-09-3034,596,044USD
At 2016-12-3132,037,431USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2017-09-3042,222,077USD
At 2016-12-3139,479,822USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2017-09-30-4,236,941USD
At 2016-12-31-3,316,941USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2017-09-30393,311USD
At 2016-12-31221,962USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2017-07-01 to 2017-09-30-449,044USD92
2017-01-01 to 2017-09-30-1,372,345USD273
2016-07-01 to 2016-09-30313,822USD92
2016-01-01 to 2016-09-30-411,666USD274

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2017-07-01 to 2017-09-30-456,544USD92
2017-01-01 to 2017-09-30-1,372,795USD273
2016-07-01 to 2016-09-30348,327USD92
2016-01-01 to 2016-09-30-318,799USD274

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2017-07-01 to 2017-09-30313,764USD92
2017-01-01 to 2017-09-30876,623USD273
2016-07-01 to 2016-09-30734,891USD92
2016-01-01 to 2016-09-301,616,476USD274

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2017-07-01 to 2017-09-30319,864USD92
2017-01-01 to 2017-09-30920,001USD273
2016-07-01 to 2016-09-30287,389USD92
2016-01-01 to 2016-09-301,182,849USD274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2017-07-01 to 2017-09-30535,930USD92
2017-01-01 to 2017-09-301,503,905USD273
2016-07-01 to 2016-09-30-528,837USD92
2016-01-01 to 2016-09-30648,804USD274

Inspect the source

Entity
Selectis Health, Inc. / CIK 0000727346
Captured
2026-09-19T15:00:26.408Z
SEC response SHA-256
98084fe11a07b9229eef60550e570fcfec8f48e5c4750b74ebaa187a5d31ada2

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000727346.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))